TH16087A - ยารักษาโรคเบาหวานชนิดสูดดม - Google Patents
ยารักษาโรคเบาหวานชนิดสูดดมInfo
- Publication number
- TH16087A TH16087A TH9401001281A TH9401001281A TH16087A TH 16087 A TH16087 A TH 16087A TH 9401001281 A TH9401001281 A TH 9401001281A TH 9401001281 A TH9401001281 A TH 9401001281A TH 16087 A TH16087 A TH 16087A
- Authority
- TH
- Thailand
- Prior art keywords
- insulin
- holds
- active compound
- specific characteristics
- medicine
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract 60
- 229940079593 drug Drugs 0.000 title claims abstract 33
- 206010012601 diabetes mellitus Diseases 0.000 title claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract 86
- 102000004877 Insulin Human genes 0.000 claims abstract 44
- 108090001061 Insulin Proteins 0.000 claims abstract 44
- 229940125396 insulin Drugs 0.000 claims abstract 43
- 238000010521 absorption reaction Methods 0.000 claims abstract 20
- 239000000126 substance Substances 0.000 claims abstract 20
- 210000002345 respiratory system Anatomy 0.000 claims abstract 10
- 150000001875 compounds Chemical class 0.000 claims 52
- 239000000843 powder Substances 0.000 claims 30
- 239000002245 particle Substances 0.000 claims 22
- 239000013589 supplement Substances 0.000 claims 13
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims 6
- 239000000654 additive Substances 0.000 claims 6
- 229960004203 carnitine Drugs 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 239000003937 drug carrier Substances 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 6
- -1 trehelose Chemical compound 0.000 claims 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 5
- 230000000996 additive effect Effects 0.000 claims 5
- 239000003833 bile salt Substances 0.000 claims 5
- 239000000969 carrier Substances 0.000 claims 5
- 229930182470 glycoside Natural products 0.000 claims 5
- 230000029058 respiratory gaseous exchange Effects 0.000 claims 5
- 229910052708 sodium Inorganic materials 0.000 claims 5
- 239000011734 sodium Substances 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 239000000955 prescription drug Substances 0.000 claims 4
- 229940093761 bile salts Drugs 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 230000004936 stimulating effect Effects 0.000 claims 3
- 101710186630 Insulin-1 Proteins 0.000 claims 2
- 230000001851 biosynthetic effect Effects 0.000 claims 2
- 238000000227 grinding Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 claims 1
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 claims 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims 1
- 229960001009 acetylcarnitine Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000003945 anionic surfactant Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- 239000011362 coarse particle Substances 0.000 claims 1
- 229940000425 combination drug Drugs 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims 1
- 239000000832 lactitol Substances 0.000 claims 1
- 235000010448 lactitol Nutrition 0.000 claims 1
- 229960003451 lactitol Drugs 0.000 claims 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 1
- 239000000845 maltitol Substances 0.000 claims 1
- 235000010449 maltitol Nutrition 0.000 claims 1
- 229940035436 maltitol Drugs 0.000 claims 1
- QZIQJVCYUQZDIR-UHFFFAOYSA-N mechlorethamine hydrochloride Chemical compound Cl.ClCCN(C)CCCl QZIQJVCYUQZDIR-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000003904 phospholipids Chemical group 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 239000011164 primary particle Substances 0.000 claims 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 claims 1
- 229940126585 therapeutic drug Drugs 0.000 claims 1
Abstract
ยาสำหรับการสูดดม ซึ่งประกอบด้วยอินซูลิน และสารชนิดหนึ่งที่เสริมการดูดซึมของอินซูลิน ในทางเดนหายใจตอนล่าง,ที่ถูกทำให้อยู่ในรูปของยาชนิดหนึ่งที่เหมาะสมสำหรับการสูดดม สิทธิบัตรยา
Claims (4)
1. การใช้ตามข้อถือสิทธิ 58 ซึ่งสารเสริมนั้น เป็นโซเดียมทอโรโคเลท 6
2. การใช้ตามข้อถือสิทธิ 58 ซึ่งสารเสริมนั้น เป็น แอซิลคาร์นิทิน 6
3. การใช้ตามข้อถือสิทธิ 58 ซึ่งสารเสริมนั้น เป็น แอลคิล ไกลโคไซด์ 6
4. การใช้ยารักษาโรคชนิดหนึ่ง ดังที่ถือสิทธิในข้อถือสิทธิ 1 ถึง 43 ข้อใดข้อหนึ่ง สำหรับการผลิตยาสำหรับการบำบัดโรคเบาหวาน
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH16087A true TH16087A (th) | 1995-06-23 |
| TH11083B TH11083B (th) | 2001-10-10 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1007017B2 (en) | Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof | |
| CN1222282C (zh) | 注入堆积密度为0.28~0.38g/ml的含有布地奈德的吸入用新配方 | |
| NZ504711A (en) | Soft-pellet drug and process for the preparation thereof | |
| CN1213741C (zh) | 注入堆积密度为0.28~0.38g/ml的含福莫特罗的吸入用新配方 | |
| CA3162623A1 (en) | Aerosolization systems, methods, and apparatuses | |
| AU728768B2 (en) | New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof | |
| TH16087A (th) | ยารักษาโรคเบาหวานชนิดสูดดม | |
| TH11083B (th) | ยารักษาโรคเบาหวานชนิดสูดดม | |
| DE69917658T3 (de) | Micronisierte pharmazeutische zusammensetzungen | |
| MX2007001348A (es) | Composiciones de vitamina b12. | |
| Matsusaka et al. | Effect of nickel ferrocyanide-anion exchange resin and several metal ferrocyanides on the enhancement of 137Cs excretion in mice | |
| JP4512202B6 (ja) | ブデソニドを含む0.28から0.38g/MLのかさ密度を有する吸入用新規製剤 | |
| BIOMEDICAL et al. | NEW FINDINGS REGARDING THE BIOMEDICAL IMPACT AND THE ANTITUMOR POTENTIAL OF ZEOLITES | |
| Gomes et al. | Model to evaluate the biological effect of the mitomycin-c: study of the biodistribution of radiopharmaceutical in mice | |
| DE3224779A1 (de) | Arzneimittel zur behandlung von tumoren |